Insider

Jason Pitofsky

SVP Controller · Regeneron Pharmaceuticals, Inc. (REGN)

sold: $3,827,159 · planned sales: $3,789,808

DateTradeSharesAvg. priceValueFiling
November 4, 2026Planned sale3,883—$3,789,808SEC
November 4, 2026Sale4,062$942.19$3,827,159SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.